Institutional investors purchased a net $792.4 thousand shares of GHDX during the quarter ended December 2013, and now own 88.50% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAILLIE GIFFORD & CO. Bought 317.5 Thousand shares of Genomic Health Inc
LORD, ABBETT & CO. LLC Bought 260.9 Thousand shares of Genomic Health Inc
BAKER BROS. ADVISORS LP Bought 193.8 Thousand shares of Genomic Health Inc